Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9012624

Compositions and methods for inhibiting expression of a gene from the JC virus

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9012134

CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs

The Regents of the University of California · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9006197

Compositions and methods for inhibiting expression of Eg5 and VEGF genes

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9000143

Compositions and methods for inhibiting expression of IKK-B gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9000089

Polyurea systems, processes for preparing the same and use thereof for postoperative adhes

Medical Adhesive Revolution GmbH · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987227

Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8986688

WAP domain fusion polypeptides and methods of use thereof

Inhibrx, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8986695

Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8989847

Method of measuring propulsion in lymphatic structures

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987426

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8981057

B-cell stimulating fusion proteins of an antigen with BAFF or APRIL

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980266

Serpin fusion polypeptides and methods of use thereof

Inhibrx, Inc. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8975295

Modulation of zinc levels to improve tissue properties

Precision Dermatology, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8974801

Long term sustained release pharmaceutical composition containing aqueous suspension of bi

Amphastar Pharmaceuticals, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969409

Treatment for pulmonary hypertension

United Therapeutics Corporation · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969077

Neuronal specific targeting of caveolin expression to restore synaptic signaling and impro

The Regents of the University of California · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962026

Nanoemulsion therapeutic compositions and methods of using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962588

Micro-RNAS that control myosin expression and myofiber identity

The Board of Regents of the University of Texas System · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957031

Competitive inhibitors of invariant chain expression and/or ectopic clip binding

The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8951971

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8951968

Methods of treating depression and other related diseases

Northwestern University · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946176

Compositions and methods for inhibiting expression of RRM2 genes

Arrowhead Research Corporation · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8940701

Compounds for, and methods of, treating cancer and inhibiting invasion and metastases

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8940690

Synthetic conjugates and uses thereof

The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted